- Nadish Garg, MD, FASE, FACC
- Phone: 832-328-8551
- Mon-Fri (8:30am - 5pm)
- Patient Portal
- Stroke risk is 5-fold with Atrial fibrillation
- The LAAO Implant is an innovative one-time procedure designed to reduce the risk of strokes that originate in the left atrial appendage (LAA)
- Criteria: CHADS2-VASC >3
- Patient with elevated HAS-BLED score: High risk of 10-year re-bleeding
- B/w 30-50% eligible patients with Atrial fibrillation still not on AC
- LAAO high success rate and low complication rate
- Stroke prevention is comparable to Oral AC
Potential candidates:
History of bleeding
Increased bleeding risk based on HAS-BLED score or other factors (e.g. thrombocytopenia, cancer, or risk of tumor associated bleeding in case of systemic anticoagulation)
History or risk of falls
Documented poor compliance with OAC therapy
Inability or difficulty maintaining therapeutic range
Occupation that puts patient at an increased bleeding risk
Lifestyle or hobby that puts patient at an increased bleeding risk
Severe renal failure – medical condition for which OAC inappropriate
Avoidance of triple therapy after PCI or TAVR
Other situations for which OAC is inappropriate
Drug or medication regiment not compatible with oral anticoagulant therapy
